Medline (MDLN) Assets (2024 - 2026)

Medline (MDLN) has reported Assets for 3 consecutive years, with $39.4 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Assets changed N/A year-over-year to $39.4 billion in Q2 2026; TTM through Jun 2026 was $39.4 billion, a N/A change from a year earlier, with the FY2025 full-year figure at $38.5 billion, up 6.97% from the prior year.
• Assets was $39.4 billion for Q2 2026 at Medline, up from $39.0 billion in the prior quarter.
• Over five years, Assets peaked at $39.4 billion in Q2 2026 and troughed at $36.0 billion in Q4 2024.
• A 3-year average of $38.2 billion and a median of $38.7 billion in 2025 frame the typical range for Assets.
• The widest YoY moves for Assets: up 6.97% in 2025, down 6.97% in 2025.
• Over 3 years, Assets stood at $36.0 billion in 2024, then gained by 6.97% to $38.5 billion in 2025, then rose by 2.25% to $39.4 billion in 2026.
• The last three Assets figures came in at $39.4 billion (Q2 2026), $39.0 billion (Q1 2026), and $38.5 billion (Q4 2025), per Business Quant data.